Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
113.4 USD | -8.12% | -11.93% | +17.92% |
05:09pm | Sarepta Therapeutics Shares Fall After RBC Downgrade | MT |
12:44pm | RBC Downgrades Sarepta Therapeutics to Sector Perform From Outperform, Lowers Price Target to $142 From $157 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.92% | 11.67B | |
+9.88% | 118B | |
+10.24% | 106B | |
-11.33% | 23.4B | |
-1.69% | 22.1B | |
-10.23% | 18.34B | |
-41.92% | 16.59B | |
-15.68% | 15.97B | |
+6.83% | 14.03B | |
-31.63% | 7.55B |
- Stock Market
- Equities
- SRPT Stock
- News Sarepta Therapeutics, Inc.
- Sarepta Therapeutics' Regulatory Drug Review Underpins Prospects for Rally, RBC Says